文献速递系统性红斑狼疮

新发狼疮性肾炎医疗补助受益者在医疗利用、终末期肾病和死亡率方面的性别差异

Sex Differences in Health Care Utilization, End-Stage Renal Disease, and Mortality Among Medicaid Beneficiaries With Incident Lupus Nephritis.
PubMed 文献 · Arthritis Rheumatol · 2018-02-06

该研究基于2000至2010年29个州医疗补助分析提取数据库,识别2750例新发狼疮性肾炎患者(男性283例,占10%),链接美国肾脏数据系统和社会安全死亡索引,比较男女在医疗利用、终末期肾病和死亡上的差异。结果显示男性门诊和急诊就诊次数更少,但终末期肾病和死亡风险无性别差异。

要点

  • 新发狼疮性肾炎医疗补助人群中男性占10%。
  • 男性门诊就诊率IRR 0.88,急诊就诊率IRR 0.75,均低于女性。
  • 男女5年终末期肾病累积发生率分别为22.3%和21.2%,死亡为9.4%和9.8%,风险无显著差异。

核心结论

  • 在新发狼疮性肾炎队列中,终末期肾病和死亡率总体极高,但男性相比女性并未增加。
  • 在该脆弱人群中,性别相关的生物学和医疗利用差异可能不会显著影响结局。

研究设计与样本

  • 研究基于医疗补助分析提取数据库(MAX)2000至2010年29个州的数据,通过账单索赔识别5至65岁新发狼疮性肾炎患者(阳性预测值80%)。
  • MAX数据链接美国肾脏数据系统确定终末期肾病,链接社会安全死亡索引文件确定死亡。
  • 采用泊松回归估计按性别的医疗利用调整发病率比(IRR),采用多变量比例风险模型比较终末期肾病和死亡风险。

主要发现

  • 共2750例新发狼疮性肾炎患者,男性283例(10%),男女平均随访时间均为3.1±2.3年。
  • 女性平均年龄29.6±13.9岁,男性24.7±14.1岁(P < 0.01)。
  • 男性门诊就诊次数较少(IRR 0.88 [95%CI 0.80-0.97]),急诊就诊次数较少(IRR 0.75 [95%CI 0.63-0.90])。
  • 男性5年终末期肾病累积发生率为22.3%,女性为21.2%;男性5年死亡累积发生率为9.4%,女性为9.8%。
  • 比较男性与女性,终末期肾病无性别差异(亚分布风险比HR 1.05 [95%CI 0.76-1.45]),死亡无性别差异(HR 0.81 [95%CI 0.47-1.35])。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: While systemic lupus erythematosus and lupus nephritis (LN) disproportionately affect females, previous studies suggest that males may experience poorer outcomes. We undertook this study to investigate sex differences in health care utilization, end-stage renal disease (ESRD), and mortality among patients with LN receiving Medicaid, public insurance for low-income individuals. METHODS: Within the Medicaid Analytic eXtract (MAX) from 29 states (from 2000 to 2010), we used billing claims to identify individuals ages 5-65 years with incident LN (positive predictive value 80%). MAX data were linked to the US Renal Data System to determine ESRD and to Social Security Death Index files to determine death. We estimated adjusted incidence rate ratios (IRRs) by sex for health care utilization using Poisson regression, and we used multivariable proportional hazards models to compare risks of ESRD and death by sex. RESULTS: Of 2,750 patients with incident LN, 283 (10%) were male. The mean ± SD follow-up period for both sexes was 3.1 ± 2.3 years. The mean ± SD age was 29.6 ± 13.9 years among females and 24.7 ± 14.1 years among males (P < 0.01). Males had fewer outpatient visits (IRR 0.88 [95% confidence interval (95% CI) 0.80-0.97]) and fewer emergency department visits (IRR 0.75 [95% CI 0.63-0.90]). The 5-year cumulative incidence of ESRD was 22.3% in males and 21.2% in females. The 5-year cumulative incidence of death was 9.4% in males and 9.8% in females. Comparing males to females, there were no sex differences in ESRD (subdistribution hazard ratio [HR] 1.05 [95% CI 0.76-1.45]) or death (HR 0.81 [95% CI 0.47-1.35]). CONCLUSION: In this cohort of patients with incident LN, ESRD and mortality were extremely high overall but were not increased among males compared to females. In this vulnerable population, biologic and health care utilization differences by sex may not significantly affect outcomes.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Feldman CH, Broder A, Guan H, et al. Sex Differences in Health Care Utilization, End-Stage Renal Disease, and Mortality Among Medicaid Beneficiaries With Incident Lupus Nephritis. Arthritis Rheumatol. 2018. PMID: 29193893. doi:10.1002/art.40392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。